Nasdaq · Healthcare

Surgery Partners, Inc. (SGRY)

As-reported financials and recent SEC filings for Surgery Partners, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$3.31B

Net income

$-77.9M

Net margin

-2.4%

Diluted EPS

$-0.61

ROE

-2.5%

P/E (TTM)

—

Market cap

$2.07B

Debt / equity

1.2×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$3.31B	$3.11B	$2.74B	$2.54B	$2.23B
Gross profit	—	—	—	—	—
Operating income	$389.5M	$348.8M	$328.0M	$345.2M	$302.2M
Net income	$-77.9M	$-168.1M	$-11.9M	$-54.6M	$-70.9M
Diluted EPS	$-0.61	$-1.33	$-0.09	$-0.59	$-1.12

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-06-09

42026-06-09

42026-06-09

42026-06-09

42026-06-09

42026-06-09

42026-06-09

8-K2026-06-05

Go deeper on SGRY

Search Surgery Partners, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.